Clinical value of immunohistochemically detected lymphovascular invasion in endometrioid endometrial cancer

Gynecologic Oncology

Volumn 92, Issue 2, 2004, Pages 653-659

  Alexander Sefre, F ^a   Singh, N ^a   Ayhan, A ^a   Thomas, J M ^a   Jacobs, I J ^a  

^a ST BARTHOLOMEW S HOSPITAL   (United Kingdom)

Author keywords

Endometrial cancer; Immunohistochemistry; LVSI; Vascular invasion

Indexed keywords

BIOTIN DERIVATIVE; CELL MARKER; EOSIN; HEMATOXYLIN; ISOENZYME; ISOPROTEIN; KERATIN; PEROXIDASE; STREPTAVIDIN; TAMOXIFEN;

ADULT; AGE DISTRIBUTION; AGED; ARTICLE; CANCER DIAGNOSIS; CANCER GRADING; CANCER INVASION; CANCER RECURRENCE; CANCER STAGING; CANCER SURVIVAL; CHI SQUARE DISTRIBUTION; CLINICAL FEATURE; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIABETES MELLITUS; DIAGNOSTIC PROCEDURE; DISEASE ASSOCIATION; ENDOMETRIOID CARCINOMA; ENDOMETRIUM CARCINOMA; ENDOTHELIUM CELL; FEMALE; FOLLOW UP; HORMONE SUBSTITUTION; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LYMPH NODE METASTASIS; LYMPH VESSEL; MAJOR CLINICAL STUDY; MEDICAL RECORD; MENOPAUSE; MOLECULAR CLONING; MOUSE; MYOMETRIUM; NONHUMAN; OBESITY; PARITY; PATIENT CODING; PRIORITY JOURNAL; RACE; RISK ASSESSMENT; STATISTICAL ANALYSIS; STATISTICAL SIGNIFICANCE;

EID: 0842310536     PISSN: 00908258     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ygyno.2003.11.012     Document Type: Article

References (38)

1. Parker S.L., Tong T., Bolden S., Wingo P.A. Cancer statistics. CA Cancer J Clin. 47:1997;5-27.
2. Barber B.R., Sommers S.C., Rotterdam H., Kwon T. Vascular invasion as a prognostic factor in stage IB cancer of the cervix. Obstet. Gynecol. 52(3):1978 (Sep);343-348.
3. Fujisawa T., Yamaguchi Y., Saitoh Y., Hiroshima K., Ohwada H. Blood and lymphatic vessel invasion as prognostic factors for patients with primary resected nonsmall cell carcinoma of the lung with intrapulmonary metastases. Cancer. 76(12):1995 (Dec 15);2464-2470.
4. Katz A., Strom E.A., Buchholz T.A., Theriault R., Singletary S.E., McNeese M.D. The influence of pathologic tumor characteristics on locoregional recurrence rates following mastectomy. Int. J. Radiat. Oncol. Biol. Phys. 50(3):2001 (Jul 1);735-742.
5. Preti M., Ronco G., Ghiringhello B., Micheletti L. Recurrent squamous cell carcinoma of the vulva: clinicopathologic determinants identifying low risk patients. Cancer. 88(8):2000 (Apr 15);1869-1876.
6. Inoue Y., Obata K., Abe K., Ohmura G., Doh K., Yoshioka T.et al. The prognostic significance of vascular invasion by endometrial carcinoma. Cancer. 78(7):1996 (Oct 1);1447-1451.
7. Bell J.G., Minnick A., Reid G.C., Judis J., Brownell M. Relationship of nonstaging pathological risk factors to lymph node metastasis and recurrence in clinical stage I endometrial carcinoma. Gynecol. Oncol. 66(3):1997 (Sep);388-392.
8. Gal D., Recio F.O., Zamurovic D., Tancer M.L. Lymphvascular space involvement - A prognostic indicator in endometrial adenocarcinoma. Gynecol. Oncol. 42(2):1991 (Aug);142-145.
9. Hanson M.B., van Nagell J.R. Jr., Powell D.E., Donaldson E.S., Gallion H., Merhige M.et al. The prognostic significance of lymph-vascular space invasion in stage I endometrial cancer. Cancer. 55(8):1985 (Apr 15);1753-1757.
10. Tornos C., Silva E.G., el-Naggar A., Burke T.W. Aggressive stage I grade 1 endometrial carcinoma. Cancer. 70(4):1992 (Aug 15);790-798.
11. Morrow C.P., Bundy B.N., Kurman R.J., Creasman W.T., Heller P., Homesley H.D.et al. Relationship between surgical-pathological risk factors and outcome in clinical stage I and II carcinoma of the endometrium: a Gynecologic Oncology Group study. Gynecol. Oncol. 40(1):1991 (Jan);55-65.
12. Ambros R.A., Kurman R.J. Identification of patients with stage I uterine endometrioid adenocarcinoma at high risk of recurrence by DNA ploidy, myometrial invasion, and vascular invasion. Gynecol. Oncol. 45(3):1992 (Jun);235-239.
13. Mariani A., Webb M.J., Keeney G.L., Aletti G., Podratz K.C. Predictors of lymphatic failure in endometrial cancer. Gynecol. Oncol. 84(3):2002 (Mar);437-442.
14. Bell J.G., Minnick A., Reid G.C., Judis J., Brownell M. Relationship of nonstaging pathological risk factors to lymph node metastasis and recurrence in clinical stage I endometrial carcinoma. Gynecol. Oncol. 66(3):1997 (Sep);388-392.
15. Watanabe M., Aoki Y., Kase H., Fujita K., Tanaka K. Low risk endometrial cancer: a study of pelvic lymph node metastasis. Int. J. Gynecol. Cancer. 13(1):2003 (Jan-Feb);38-41.
16. Alexander-Sefre F, Singh N, Ayhan A, Salveson HB, Wilbanks G, Jacobs IJ. Detection of Tumour Lymphovascular Space Invasion using Dual Cytokeratin and CD-31 Immunohistochemistry. J Clin Pathol [in press].
17. Miyake Y., Yamamoto H., Fujiwara Y., Ohue M., Sugita Y., Tomita N.et al. Extensive micrometastases to lymph nodes as a marker for rapid recurrence of colorectal cancer: a study of lymphatic mapping. Clin. Cancer Res. 7(5):2001 (May);1350-1357.
18. Clobes H., Fossa S.D., Waehre H., Jocham D., Berner A. The immunohistochemical assessment of occult regional lymph node metastases in patients with T-N-0 prostate cancer before definitive radiotherapy. BJU Int. 85(3):2000 (Feb);270-275.
19. Aalders J., Abeler V., Kolstad P., Onsrud M. Postoperative external irradiation and prognostic parameters in stage I endometrial carcinoma: clinical and histopathologic study of 540 patients. Obstet. Gynecol. 56(4):1980 (Oct);419-427.
20. Sivridis E., Buckley C.H., Fox H. The prognostic significance of lymphatic vascular space invasion in endometrial adenocarcinoma. Br. J. Obstet. Gynaecol. 94(10):1987 (Oct);991-994.
21. Obermair A., Wanner C., Bilgi S., Speiser P., Reisenberger K., Kaider A.et al. The influence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma: correlation of results from hematoxylin and eosin staining with results from immunostaining for factor VIII-related antigen. Cancer. 82(4):1998;689-896.
22. Tsuruchi N., Kaku T., Kamura T., Tsukamoto N., Tsuneyoshi M., Akazawa K. The prognostic significance of lymphovascular space invasion in endometrial cancer when conventional hemotoxylin and eosin staining is compared to immunohistochemical staining. Gynecol. Oncol. 57(3):1995;307-312.
23. Birner P., Obermair A., Schindl M., Kowalski H., Breitenecker G., Oberhuber G. Selective immunohistochemical staining of blood and lymphatic vessels reveals independent prognostic influence of blood and lymphatic vessel invasion in early-stage cervical cancer. Clin. Cancer Res. 7(1):2001 (Jan);93-97.
24. Lee K.R., Vacek P.M., Belinson J.L. Traditional and nontraditional histopathologic predictors of recurrence in uterine endometrioid adenocarcinoma. Gynecol. Oncol. 54(1):1994 (Jul);10-18.
25. Obermair A., Wanner C., Bilgi S., Speiser P., Reisenberger K., Kaider A.et al. The influence of vascular space involvement on the prognosis of patients with stage IB cervical carcinoma: correlation of results from hematoxylin and eosin staining with results from immunostaining for factor VIII-related antigen. Cancer. 82(4):1998;689-696.
26. Schoppmann S.F., Birner P., Studer P., Breiteneder-Geleff S. Lymphatic microvessel density and lymphovascular invasion assessed by anti-podoplanin immunostaining in human breast cancer. Anticancer Res. 21(4A):2001 (Jul-Aug);2351-2355.
27. Birner P., Obermair A., Schindl M., Kowalski H., Breitenecker G., Oberhuber G. Selective immunohistochemical staining of blood and lymphatic vessels reveals independent prognostic influence of blood and lymphatic vessel invasion in early-stage cervical cancer. Clin. Cancer Res. 7(1):2001 (Jan);93-97.
28. Cohn D.E., Horowitz N.S., Mutch D.G., Seok-Mo K., Manolitsas T., Fowler J.M. Should the presence of lymphvascular space involvement be used to assign patients to adjuvant therapy following hysterectomy for unstaged endometrial cancer? Gynecol. Oncol. 87(3):2002 (Dec);243-246.
29. Berclaz G., Hanggi W., Kratzer-Berger A., Altermatt H.J., Greiner R.H., Dreher E. Lymphadenectomy in high risk endometrial carcinoma stage I and II: no more morbidity and no need for external pelvic radiation. Int. J. Gynecol. Cancer. 9(4):1999 (Jul);322-328.
30. Mohan D.S., Samuels M.A., Selim M.A., Shalodi A.D., Ellis R.J., Samuels J.R.et al. Long-term outcomes of therapeutic pelvic lymphadenectomy for stage I endometrial adenocarcinoma. Gynecol. Oncol. 70(2):1998 (Aug);165-171.
31. Larson D.M., Broste S.K., Krawisz B.R. Surgery without radiotherapy for primary treatment of endometrial cancer. Obstet. Gynecol. 91(3):1998 (Mar);355-359.
32. Mulsow J., Winter D.C., O'Keane J.C., O'Connell P.R. Sentinel lymph node mapping in colorectal cancer. Br. J. Surg. 90(6):2003 (Jun);659-667.
33. Van Trappen P.O., Pepper M.S. Lymphatic dissemination of tumour cells and the formation of micrometastases. Lancet Oncol. 3(1):2002 (Jan);44-52.
34. Keene S.A., Demeure M.J. The clinical significance of micrometastases and molecular metastases. Surgery. 129(1):2001 (Jan);1-5.
35. Yabushita H., Shimazu M., Yamada H., Sawaguchi K., Noguchi M., Nakanishi M.et al. Occult lymph node metastases detected by cytokeratin immunohistochemistry predict recurrence in node-negative endometrial cancer. Gynecol. Oncol. 80(2):2001 (Feb);139-144.
36. Hachisuga T., Kaku T., Fukuda K., Eguchi F., Emoto M., Kamura T.et al. The grading of lymphovascular space invasion in endometrial carcinoma. Cancer. 86(10):1999 (Nov 15);2090-2097.
37. Nishiya M., Sakuragi N., Hareyama H., Ebina Y., Furuya M., Oikawa M.et al. Cox multivariate regression models for estimating prognosis of patients with endometrioid adenocarcinoma of the uterine corpus who underwent thorough surgical staging. Int. J. Cancer. 79(5):1998 (Oct 23);521-525.
38. Kuroki J., Hasegawa K., Kato R., Mizukawa J., Noshio E., Nishizawa H.et al. Relationship between the classification of vascular invasion severity and the prognosis of uterine endometrial cancer. Int. J. Gynecol. Oncol. 13(1):2003 (Jan);47-52.